Ep 57: Olivier Rubin & AMR governance. November update. Rifaximin & daptomycin cross-resistance.
Hitting this November month with a very relevant topic, Global Governance! In this episode, you can listen to an interview with had with Prof. Olivier Rubin, from Roskilde University in Denmark, about the social dimensions of AMR, and how AMR is a so-called “creeping crisis” globally. Olivier has years of experience researching slow-onset crisis such as famine and climate change, and has in the recent years worked intensively in AMR and the similarities and differences with such crises. Tune in to hear his insights!
In the news section, we update you on our very very busy month of November, and bring you a really important paper demonstrating the relationship between rifaximin use and daptomicin resistance in Enterococcus.
You can follow us and subscribe to our podcast to get new episodes directly in your preferred device and platform:
Relevant links:
- Dr. Olivier Rubin's page at Roskilde University
- Steering Against Superbugs - The Global Governance of Antimicrobial Resistance. Antology by Rubin & colleagues.
Further Reading:
- Policy termination made easy? The emerging trend towards sunsetting antimicrobial resistance national action plans - Paper mentioned by Prof. Rubin during the interview.
- UNGA Political Declaration: A global commitment to combat antimicrobial resistance (AMR)
- Rifaximin prophylaxis causes resistance to the last-resort antibiotic daptomycin - paper covered in the news.
- ‘Low risk’ antibiotic has led to an almost untreatable superbug - popular news coverage of the paper above at The Microbiologist.
If you have any comments and suggestions you can email us here, or tweet to us (@UAC_UU) using the hashtag #theAMRStudio.